Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00231231 · ClinicalTrials.gov registry record · Phase 3
Carotid Artery Stenting With Emboli Protection Surveillance-Post-Marketing Study (CASES-PMS)
A Phase 3 study, sponsored by Cordis US.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,500
- Enrollment target
NCT00231231: Completed Phase 3 study, sponsored by Cordis US.
NCT00231231 is a Phase 3 study that has completed, run by Cordis US. The registered enrollment target is 1,500 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (94% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00231231, a Phase 3 study, has completed, sponsored by Cordis US.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,500 participants
- Enrollment target
Study Summary
The primary objective of this study is to assess the outcomes of stenting with distal protection in the treatment of obstructive carotid artery disease during peri-approval/initial commercialization in relation to the outcomes of the Sapphire Clinical Trial. The devices to be utilized are the Cordis PRECISE Nitinol Stent Systems and the Cordis ANGIOGUARD™ XP Emboli Capture Guidewire (ECGW).
Interventions
- DEVICE -PRECISE Nitinol Stent System (5F, 5.5F and 6F)
- DEVICE ANGIOGUARD™ XP Emboli Capture Guidewire (ECGW)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2004-09 |
| Est. Completion | 2006-11 |
| Phase | Phase 3 |
What the finished NCT00231231 record still lists
NCT00231231 is an interventional study that assigns participants to a tested intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (94% higher).
The record links to 0 conditions, and to 2 interventions - of which -PRECISE Nitinol Stent System (5F, 5.5F and 6F) is the first listed.
NCT00231231 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00231231 about?
NCT00231231 is a clinical study titled "Carotid Artery Stenting With Emboli Protection Surveillance-Post-Marketing Study (CASES-PMS)". The primary objective of this study is to assess the outcomes of stenting with distal protection in the treatment of obstructive carotid artery disease during peri-approval/initial commercialization in relation to the outcomes of the Sapphire Clinical Trial. The devices to be utilized are the Cordis...
What is the current status of trial NCT00231231?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,500 participants. The study started on 2004-09. Estimated completion is 2006-11.
What interventions are being tested in trial NCT00231231?
The interventions under investigation include: -PRECISE Nitinol Stent System (5F, 5.5F and 6F) (DEVICE), ANGIOGUARD™ XP Emboli Capture Guidewire (ECGW) (DEVICE).
Who is sponsoring clinical trial NCT00231231?
This trial is sponsored by Cordis US, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00231231's enrollment target sits among peer trials
1,500 158th of 2000 higher than 1,838 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- NCT02071134 · 1,500 participants
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia